Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
US ˙ NasdaqGS ˙ US1523091007

SecurityCNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership598,197 shares
Latest Disclosed Value $ 23,760,385
Citadel Advisors Llc ownership in CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 598,197 shares of Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) (US:CNTA) valued at $23,760,385 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 519,962 shares of Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock). This represents a change in shares of 15.05% during the quarter. The current value of the position is $23,700,565 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (CNTA) in the form of stock options. The firm currently holds call options representing 83,600 of underlying shares valued at $3,320,592 USD and put options representing 48,200 of underlying shares valued at $1,914,504 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CENTESSA PHARMACEUTICALS SPONSORED ADS 152309100 598,197 78,235 15.05 23,760 82.71 0.0034
2026-02-17 2025-12-31 13F CENTESSA PHARMACEUTICALS SPONSORED ADS 152309100 519,962 382,761 278.98 13,004 290.86 0.0017
2025-11-14 2025-09-30 13F CENTESSA PHARMACEUTICALS SPONSORED ADS 152309100 137,201 137,201 3,327 0.0005
2025-08-14 2025-06-30 13F CENTESSA PHARMACEUTICALS SPONSORED ADS 152309100 0 -706,331 -100.00 0 -100.00
2025-05-15 2025-03-31 13F CENTESSA PHARMACEUTICALS SPONSORED ADS 152309100 706,331 81,015 12.96 10,157 -3.03 0.0019
2025-02-14 2024-12-31 13F CENTESSA PHARMACEUTICALS SPONSORED ADS 152309100 625,316 37,798 6.43 10,474 11.50 0.0018
2024-11-14 2024-09-30 13F CENTESSA PHARMACEUTICALS SPONSORED ADS 152309100 587,518 549,242 1,434.95 9,394 2,622.90 0.0018
2024-08-14 2024-06-30 13F CENTESSA PHARMACEUTICALS SPONSORED ADS 152309100 38,276 -8,692 -18.51 346 -34.91 0.0001
2024-05-15 2024-03-31 13F CENTESSA PHARMACEUTICALS SPONSORED ADS 152309100 46,968 -53,836 -53.41 531 -33.92 0.0001
2024-02-14 2023-12-31 13F CENTESSA PHARMACEUTICALS SPONSORED ADS 152309100 100,804 97,785 3,238.99 802 4,121.05 0.0002
2023-11-14 2023-09-30 13F CENTESSA PHARMACEUTICALS SPONSORED ADS 152309100 3,019 -1,086 -26.46 20 -24.00 0.0000
2023-08-14 2023-06-30 13F CENTESSA PHARMACEUTICALS SPONSORED ADS 152309100 4,105 4,105 25 0.0000
2023-05-15 2023-03-31 13F CENTESSA PHARMACEUTICALS SPONSORED ADS 152309100 0 -72,307 -100.00 0 -100.00
2023-02-14 2022-12-31 13F CENTESSA PHARMACEUTICALS SPONSORED ADS 152309100 72,307 -153,061 -67.92 224 -75.28 0.0001
2022-11-14 2022-09-30 13F CENTESSA PHARMACEUTICALS SPONSORED ADS 152309100 225,368 -65,215 -22.44 906 -35.97 0.0002
2022-08-15 2022-06-30 13F CENTESSA PHARMACEUTICALS SPONSORED ADS 152309100 290,583 -13,843 -4.55 1,415 -48.19 0.0004
2022-05-16 2022-03-31 13F CENTESSA PHARMACEUTICALS SPONSORED ADS 152309100 304,426 -35,639 -10.48 2,731 -28.68 0.0006
2022-02-14 2021-12-31 13F CENTESSA PHARMACEUTICALS SPONSORED ADS 152309100 340,065 -9,483 -2.71 3,829 -34.40 0.0008
2021-11-15 2021-09-30 13F CENTESSA PHARMACEUTICALS Depository Receipt 152309100 349,548 -106,685 -23.38 5,837 -42.40 0.0012
2021-08-16 2021-06-30 13F CENTESSA PHARMACEUTICALS SPONSORED ADS 152309100 456,233 456,233 10,133 0.0023
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Call 83,600 271.56 3,321 490.75 n/a n/a n/a
2026-02-17 2025-12-31 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Call 22,500 -28.80 563 -26.63 n/a n/a n/a
2025-11-14 2025-09-30 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Call 31,600 -10.99 766 64.38 n/a n/a n/a
2025-08-14 2025-06-30 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Call 35,500 107.60 466 90.20 n/a n/a n/a
2025-05-15 2025-03-31 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Call 17,100 144.29 246 109.40 n/a n/a n/a
2025-02-14 2024-12-31 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Call 7,000 18.64 117 24.47 n/a n/a n/a
2024-11-14 2024-09-30 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Call 5,900 -51.24 94 -13.76 n/a n/a n/a
2024-08-14 2024-06-30 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Call 12,100 -31.64 109 -45.50 n/a n/a n/a
2024-05-15 2024-03-31 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Call 17,700 84.38 200 163.16 n/a n/a n/a
2024-02-14 2023-12-31 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Call 9,600 37.14 76 68.89 n/a n/a n/a
2023-11-14 2023-09-30 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Call 7,000 483.33 45 542.86 n/a n/a n/a
2023-08-14 2023-06-30 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Call 1,200 7 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Put 48,200 28.88 1,915 104.71 n/a n/a n/a
2026-02-17 2025-12-31 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Put 37,400 -60.63 935 -59.40 n/a n/a n/a
2025-11-14 2025-09-30 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Put 95,000 137.50 2,304 338.67 n/a n/a n/a
2025-08-14 2025-06-30 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Put 40,000 132.56 526 112.55 n/a n/a n/a
2025-05-15 2025-03-31 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Put 17,200 4,200.00 247 4,016.67 n/a n/a n/a
2025-02-14 2024-12-31 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Put 400 -98.64 7 -98.73 n/a n/a n/a
2024-11-14 2024-09-30 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Put 29,500 883.33 472 1,644.44 n/a n/a n/a
2024-08-14 2024-06-30 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Put 3,000 -40.00 27 -51.79 n/a n/a n/a
2024-05-15 2024-03-31 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Put 5,000 25.00 56 80.65 n/a n/a n/a
2024-02-14 2023-12-31 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Put 4,000 90.48 32 138.46 n/a n/a n/a
2023-11-14 2023-09-30 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Put 2,100 -60.38 14 -59.37 n/a n/a n/a
2023-08-14 2023-06-30 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Put 5,300 33 n/a n/a n/a
2023-05-15 2023-03-31 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F CENTESSA PHARMACEUTICALS SPONSORED ADS Put 1,000 3 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.